Instead of simply blocking HIV from replicating, a new drug in trial stages causes it to mutate. If it works, it could eventually fully eliminate HIV in people who have the disease, freeing them from a lifetime of drugs. Koronis Pharmaceuticals, a Seattle-based biotech company, has a potential solution to the HIV epidemic with KP-1461, a new kind of drug that essentially mutates HIV into oblivion. If it works, patients could eventually get off the drug altogether and remain HIV-free.




Apple Needs to Make it in America
